4//SEC Filing
STAMBAUGH LARRY G 4
Accession 0001104659-06-001042
CIK 0001013351other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 6:50 PM ET
Size
7.0 KB
Accession
0001104659-06-001042
Insider Transaction Report
Form 4
STAMBAUGH LARRY G
DirectorChairman,CEO and President
Transactions
- Disposition to Issuer
Common Stock
2006-01-04−3,657→ 0 total - Disposition to Issuer
Common Stock
2006-01-04−10,000→ 0 total(indirect: By Spouse)
Footnotes (1)
- [F1]Disposed of pursuant to an Agreement and Plan of Merger among issuer, EpiCept Corporation and Magazine Acquisition Corp., dated September 6, 2005, in exchange for 0.203969 shares of EpiCept common stock and cash for fractional shares of EpiCept common stock equal to approximately $1.134 per share. Because there was no public market for the EpiCept common stock at the effective time of the merger, the market value of such stock was not determinable.
Documents
Issuer
MAXIM PHARMACEUTICALS INC
CIK 0001013351
Entity typeother
Related Parties
1- filerCIK 0001215909
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 6:50 PM ET
- Size
- 7.0 KB